[1] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. [2] 孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤,2019,28(1) :1-11. [3] 李伟伟,周金意,董建梅,等.2015年江苏省甲状腺癌流行现状及2006—2015年趋势分析[J].实用肿瘤学杂志,2021,35(1):1-6. [4] Global Burden of Disease Collaborators Network. Global Burden of Disease Study2019(GBD 2019)result[EB/OL].(2020-10-20)[2021-03-20].http://ghdx.healthdata.org/gbd-results-tool. [5] Vos T, Lim SS, Abbafati C, et al.Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222. [6] Murray CJL, Aravkin AY, Zheng P, et al.Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1223-1249. [7] 李辉章,杜灵彬.Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J].中华预防医学杂志,2020,54(8): 908-912. [8] 孙嘉伟,许晓君,蔡秋茂,等.中国甲状腺癌发病趋势分析[J].中国肿瘤,2013,22(9): 690-693. [9] Li M, Zheng R, Maso LD, et al.Mapping overdiagnosis of thyroid cancer in China[J].Lancet Diabetes Endocrinol,2021,9(6):330-332. [10] Kitahara CM, Pfeiffer RM, Sosa JA, et al.Impact of overweight and obesity on US papillary thyroid cancer incidence trends(1995-2015)[J].J Natl Cancer Inst Monogr, 2019,112(8):810-817. [11] Wang J, Yu F, Shang Y, et al.Thyroid cancer: Incidence and mortality trends in China, 2005-2015[J].Endocrine,2020,68(5):163-173. [12] 江苏省统计局.江苏省国民经济和社会发展统计公报[EB/OL]. (2017-02-27)[2021-03-20].http://tj.jiangsu.gov.cn/art/2017/2/27/art_4033_2279697.html. [13] 曾玉环,夏亮,许燕君,等.2014年广东省肿瘤登记地区恶性肿瘤发病和死亡分析[J].华南预防医学,2021,47(5):623-626. [14] 梁大艳,林绍良,陈剑雄,等.2014—2016年肇庆市端州区恶性肿瘤发病与死亡分析[J].华南预防医学,2021,47(8):968-971. [15] Cordina-Duverger E,Leux C,Neri M,et al.Hormonal and reproductive risk factors of papillary thyroid cancer: A population-based case-control study in France[J].Cancer Epidemiol,2017,48(3):78–84. [16] 李斐,李舍予.全球甲状腺癌疾病负担[J].中国全科医学,2018,21(26):3155-3159. [17] 中国抗癌协会头颈肿瘤专业委员会.分化型甲状腺癌诊治指南[J].中国实用外科杂志,2011, 31(10):908-914. [18] 中华人民共和国卫生部.《公共场所卫生管理条例实施细则》[EB/OL]. (2011-03-22)[2021-03-20].http://www.gov.cn/flfg/2011-03/22/content_1829432.html. |